home
JAMA Oncology Author Interviews

Advertise on podcast: JAMA Oncology Author Interviews

Rating
3.8
from
11 reviews
This podcast has
129 episodes
Language
English
Publisher
JAMA Network
Explicit
No
Date created
2017/05/05
Latest episode
2025/11/26
Average duration
17 min.
Release period
36 days

Description

Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

Unlock JAMA Oncology Author Interviews podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Social media

Check JAMA Oncology Author Interviews social media presence

Podcast episodes

Check latest episodes from JAMA Oncology Author Interviews podcast

Metastatic Recurrence Among Adolescents and Young Adults With Cancer
2025/11/26
Interview with Ann Brunson, MS, and Theresa H. M. Keegan, PhD, MS, authors of Metastatic Recurrence Among Adolescents and Young Adults With Cancer. Hosted by Vivek Subbiah, MD. Related Content: Metastatic Recurrence Among Adolescents and Young Adults With Cancer Metastatic Recurrence in Adolescent and Young Adult Cancer—Key Drivers of Early Mortality
more
Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality
2025/10/30
Interview with Yiwen Zhang, PhD, and Edward L. Giovannucci, MD, ScD, authors of Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality. Hosted by Vivek Subbiah, MD. Related Content: Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality Long-Term Physical Activity for Prevention of Digestive System Cancers—Consistency Is Key
more
Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer
2025/09/18
Interview with Jiyoung Ahn, PhD, author of Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. Hosted by Vivek Subbiah, MD. Related Content: Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer
more
Proportional Sedation for Persistent Agitated Delirium in Palliative Care
2025/07/31
Interview with David Hui, MD, and Eduardo Bruera, MD, authors of Proportional Sedation for Persistent Agitated Delirium in Palliative Care: A Randomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Proportional Sedation for Persistent Agitated Delirium in Palliative Care
more
New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
2025/05/29
Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. Hosted by Vivek Subbiah, MD. Related Content: New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
more
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury
2025/04/24
Interview with Shruti Gupta, MD, MPH, author of Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury. Hosted by Vivek Subbiah, MD. Related Content: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury
more
Accelerated Aging in Survivors of Childhood Cancer
2025/03/20
Interview with Jennifer M. Yeh, PhD, and Lisa R. Diller, MD, authors of Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions. Hosted by Vivek Subbiah, MD. Related Content: Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions On Accelerated Aging—A Phenomenon in Survivors of Childhood Cancer
more
Academic-Community Partnership and Deaths in Promyelocytic Leukemia
2025/02/27
Interview with Anand P. Jillella, MD, author of Academic-Community Partnership and Deaths in Promyelocytic Leukemia: The Nonrandomized ECOG-ACRIN EA9131 Trial. Hosted by Vivek Subbiah, MD. Related Content: Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality
more
Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy
2025/01/30
Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD. Related Content: Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy
more
Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020
2024/12/05
Interview with Katrina A. B. Goddard, PhD, author of Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020. Hosted by Vivek Subbiah, MD. Related Content: Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020
more
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
2024/11/21
Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
more
Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
2024/10/24
Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
more
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
2024/09/05
Interview with Eileen M. O'Reilly, MD, author of Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer. Hosted by Vivek Subbiah, MD. Related Content: Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
more
Identification of Immune Checkpoint Inhibitor–Induced Diabetes
2024/08/29
Interview with Michelle Rengarajan, MD, PhD, author of Identification of Immune Checkpoint Inhibitor–Induced Diabetes. Hosted by Vivek Subbiah, MD. Related Content: Identification of Immune Checkpoint Inhibitor–Induced Diabetes
more
Neoadjuvant Exercise Therapy in Prostate Cancer
2024/07/18
Interview with Lee W. Jones, PhD, author of Neoadjuvant Exercise Therapy in Prostate Cancer: A Phase 1, Decentralized Nonrandomized Controlled Trial. Hosted by Vivek Subbiah, MD. Related Content: Neoadjuvant Exercise Therapy in Prostate Cancer
more

Podcast reviews

Read JAMA Oncology Author Interviews podcast reviews

3.8 out of 5
11 reviews
HamletDemetrius 2019/03/24
Good podcast
Love these JAMA podcasts, I work in oncology and this helps keep me up to date.
check all reviews on apple podcasts

Podcast sponsorship advertising

Start advertising on JAMA Oncology Author Interviews & sponsor relevant audience podcasts

What do you want to promote?

Ad Format

Campaign Budget

Business Details

You may also like to advertise on these Podcasts

Marketing Agencies

Brands Solutions

About

Stay updated

linkedin twitter facebook
© 2026 Podvertise.fm All Rights Reserved.